It is crucial but challenging to keep physiologic conditions during the cultivation of 3D cell scaffold constructs for the optimization of 3D cell culture processes. Therefore, we demonstrate the benefits of a recently developed miniaturized perfusion bioreactor together with a specialized incubator system that allows for the cultivation of multiple samples while screening different conditions. Hence, a decellularized bone matrix was tested towards its suitability for 3D osteogenic differentiation under flow perfusion conditions. Subsequently, physiologic shear stress and hydrostatic pressure (HP) conditions were optimized for osteogenic differentiation of human mesenchymal stem cells (MSCs). X-ray computed microtomography and scanning electron microscopy (SEM) revealed a closed cell layer covering the entire matrix. Osteogenic differentiation assessed by alkaline phosphatase activity and SEM was found to be increased in all dynamic conditions. Furthermore, screening of different fluid shear stress (FSS) conditions revealed 1.5 mL/min (equivalent to ∼10 mPa shear stress) to be optimal. However, no distinct effect of HP compared to flow perfusion without HP on osteogenic differentiation was observed. Notably, throughout all experiments, cells cultivated under FSS or HP conditions displayed increased osteogenic differentiation, which underlines the importance of physiologic conditions. In conclusion, the bioreactor system was used for biomaterial testing and to develop and optimize a 3D cell culture process for the osteogenic differentiation of MSCs. Due to its versatility and higher throughput efficiency, we hypothesize that this bioreactor/incubator system will advance the development and optimization of a variety of 3D cell culture processes.

Keywords:
Perfusion bioreactor system, Dynamic cultivation, 3D cell culture, Fluid shear stress, Hydrostatic pressure
1.
Bancroft, G.N., V.I. Sikavitsas, J. Van Den Dolder, T.L. Sheffield, C.G. Ambrose, J.A. Jansen, A.G. Mikos (2002) Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 99: 12600-12605.
2.
Becquart, P., M. Cruel, T. Hoc, L. Sudre, K. Pernelle, R. Bizios, D. Logeart-Avramoglou, H. Petite, M. Bensidhoum (2016) Human mesenchymal stem cell responses to hydrostatic pressure and shear stress. Eur Cell Mater 31: 160.
3.
Bieback, K. (2013) Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfus Med Hemother 40: 326-335.
4.
Bouxsein, M.L., S.K. Boyd, B.A. Christiansen, R.E. Guldberg, K.J. Jepsen, R. Müller (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25: 1468-1486.
5.
Braccini, A., D. Wendt, C. Jaquiery, M. Jakob, M. Heberer, L. Kenins, A. Wodnar-Filipowicz, R. Quarto, I. Martin (2005) Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23: 1066-1072.
6.
Cholewa, D., T. Stiehl, A. Schellenberg, G. Bokermann, S. Joussen, C. Koch, T. Walenda, N. Pallua, A. Marciniak-Czochra, C.V. Suschek (2011) Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant 20: 1409-1422.
7.
Ding, M., S.S. Henriksen, D. Wendt, S. Overgaard (2016) An automated perfusion bioreactor for the streamlined production of engineered osteogenic grafts. J Biomed Mater Res B Appl Biomater 104: 532-537.
8.
Doucet, C., I. Ernou, Y. Zhang, J.R. Llense, L. Begot, X. Holy, J.J. Lataillade (2005) Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
9.
Filipowska, J., G.C. Reilly, A.M. Osyczka (2016) A single short session of media perfusion induces osteogenesis in hBMSCs cultured in porous scaffolds, dependent on cell differentiation stage. Biotechnol Bioeng 113: 1814-1824.
10.
Fröhlich, M., W.L. Grayson, D. Marolt, J.M. Gimble, N. Kregar-Velikonja, G. Vunjak-Novakovic (2009) Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A 16: 179-189.
11.
Gardel, L.S., C. Correia-Gomes, L.A. Serra, M.E. Gomes, R.L. Reis (2013) A novel bidirectional continuous perfusion bioreactor for the culture of large-sized bone tissue-engineered constructs. J Biomed Mater Res B Appl Biomater 101: 1377-1386.
12.
Goldstein, A.S., T.M. Juarez, C.D. Helmke, M.C. Gustin, A.G. Mikos (2001) Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 22: 1279-1288.
13.
Grayson, W.L., S. Bhumiratana, C. Cannizzaro, P.-H.G. Chao, D.P. Lennon, A.I. Caplan, G. Vunjak-Novakovic (2008) Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A 14: 1809-1820.
14.
Grellier, M., R. Bareille, C. Bourget, J. Amédée (2009) Responsiveness of human bone marrow stromal cells to shear stress. J Tissue Eng Regen Med 3: 302-309.
15.
Gugerell, A., A. Neumann, J. Kober, L. Tammaro, E. Hoch, M. Schnabelrauch, L. Kamolz, C. Kasper, M. Keck (2015) Adipose-derived stem cells cultivated on electrospun L-lactide/glycolide copolymer fleece and gelatin hydrogels under flow conditions - aiming physiological reality in hypodermis tissue engineering. Burns 41: 163-171.
16.
Gurkan, U.A., O. Akkus (2008) The mechanical environment of bone marrow: a review. Ann Biomed Eng 36: 1978-1991.
17.
Guyot, Y., F. Luyten, J. Schrooten, I. Papantoniou, L. Geris (2015) A three-dimensional computational fluid dynamics model of shear stress distribution during neotissue growth in a perfusion bioreactor. Biotechnol Bioeng 112: 2591-2600.
18.
Hemeda, H., B. Giebel, W. Wagner (2014) Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy 16: 170-180.
19.
Huang, C., R. Ogawa (2012) Effect of hydrostatic pressure on bone regeneration using human mesenchymal stem cells. Tissue Eng Part A 18: 2106-2113.
20.
Jeong, J.Y., S.H. Park, J.W. Shin, Y.G. Kang, K.-H. Han, J.-W. Shin (2012) Effects of intermittent hydrostatic pressure magnitude on the chondrogenesis of MSCs without biochemical agents under 3D co-culture. J Mater Sci Mater Med 23: 2773-2781.
21.
Jungreuthmayer, C., S.W. Donahue, M.J. Jaasma, A.A. Al-Munajjed, J. Zanghellini, D.J. Kelly, F.J. O'Brien (2008) A comparative study of shear stresses in collagen-glycosaminoglycan and calcium phosphate scaffolds in bone tissue-engineering bioreactors. Tissue Eng Part A 15: 1141-1149.
22.
Kim, S.H., Y.R. Choi, M.S. Park, J.W. Shin, K.D. Park, S.J. Kim, J.W. Lee (2007) ERK 1/2 activation in enhanced osteogenesis of human mesenchymal stem cells in poly(lactic-glycolic acid) by cyclic hydrostatic pressure. J Biomed Mater Res A 80: 826-836.
23.
Kleinhans, C., R.R. Mohan, G. Vacun, T. Schwarz, B. Haller, Y. Sun, A. Kahlig, P. Kluger, A. Finne-Wistrand, H. Walles (2015) A perfusion bioreactor system efficiently generates cell-loaded bone substitute materials for addressing critical size bone defects. Biotechnol J 10: 1727-1738.
24.
Ladd, M.R., S.J. Lee, A. Atala, J.J. Yoo (2008) Bioreactor maintained living skin matrix. Tissue Eng Part A 15: 861-868.
25.
Li, Z., S.-J. Yao, M. Alini, M.J. Stoddart (2009) Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. Tissue Eng Part A 16: 575-584.
26.
Limaye, A. (2012) Drishti-volume exploration and presentation tool. Proc Spie, pp 85060X.
27.
Lohmann, M., G. Walenda, H. Hemeda, S. Joussen, W. Drescher, S. Jockenhoevel, G. Hutschenreuter, M. Zenke, W. Wagner (2012) Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One 7: e37839.
28.
Maes, F., T. Claessens, M. Moesen, H. Van Oosterwyck, P. Van Ransbeeck, P. Verdonck (2012) Computational models for wall shear stress estimation in scaffolds: a comparative study of two complete geometries. J Biomech 45: 1586-1592.
29.
McGowan, B. (2014) The Effects of Applied Hydrostatic Pressure on Osteogenic Differentiation of Mouse Mesenchymal Stem Cells in an in vitro 3D Culture; thesis. Clemson University, Clemson.
30.
Metscher, B.D. (2009) MicroCT for developmental biology: a versatile tool for high-contrast 3D imaging at histological resolutions. Dev Dyn 238: 632-640.
31.
Neumann, A., A. Lavrentieva, A. Heilkenbrinker, M. Loenne, C. Kasper (2014) Characterization and application of a disposable rotating bed bioreactor for mesenchymal stem cell expansion. Bioengineering 1: 231-245.
32.
Piola, M., M. Soncini, M. Cantini, N. Sadr, G. Ferrario, G.B. Fiore (2013) Design and functional testing of a multichamber perfusion platform for three-dimensional scaffolds. ScientificWorldJournal 2013: 123974.
33.
Sharp, L.A., Y.W. Lee, A.S. Goldstein (2009) Effect of low-frequency pulsatile flow on expression of osteoblastic genes by bone marrow stromal cells. Ann Biomed Eng 37: 445-453.
34.
Sikavitsas, V.I., G.N. Bancroft, H.L. Holtorf, J.A. Jansen, A.G. Mikos (2003) Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 100: 14683-14688.
35.
Sikavitsas, V.I., G.N. Bancroft, A.G. Mikos (2002) Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 62: 136-148.
36.
Song, L., Q. Zhou, P. Duan, P. Guo, D. Li, Y. Xu, S. Li, F. Luo, Z. Zhang (2012) Successful development of small diameter tissue-engineering vascular vessels by our novel integrally designed pulsatile perfusion-based bioreactor. PLoS One 7: e42569.
37.
Steward, A.J., D.J. Kelly (2015) Mechanical regulation of mesenchymal stem cell differentiation. J Anat 227: 717-731.
38.
Stiehler, M., C. Bünger, A. Baatrup, M. Lind, M. Kassem, T. Mygind (2009) Effect of dynamic 3-D culture on proliferation, distribution, and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res A 89: 96-107.
39.
Volkmer, E., I. Drosse, S. Otto, A. Stangelmayer, M. Stengele, B.C. Kallukalam, W. Mutschler, M. Schieker (2008) Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A 14: 1331-1340.
40.
Vossenberg, P., G.A. Higuera, G. van Straten, C.A. van Blitterswijk, A.J.B. van Boxtel (2009) Darcian permeability constant as indicator for shear stresses in regular scaffold systems for tissue engineering. Biomech Model Mechanobiol 8: 499-507.
41.
Wang, S., J.M. Tarbell (2000) Effect of fluid flow on smooth muscle cells in a 3-dimensional collagen gel model. Arterioscler Thromb Vasc Biol 20: 2220-2225.
42.
Wang, T.W., H.C. Wu, H.Y. Wang, F.H. Lin, J.S. Sun (2009) Regulation of adult human mesenchymal stem cells into osteogenic and chondrogenic lineages by different bioreactor systems. J Biomed Mater Res A 88: 935-946.
43.
Weinbaum, S., S.C. Cowin, Y. Zeng (1994) A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech 27: 339-360.
44.
Wendt, D., A. Marsano, M. Jakob, M. Heberer, I. Martin (2003) Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng 84: 205-214.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.